Improvement in Prognosis of Myocardial Infarction by Long-term Beta-adrenoreceptor Blockade Using Practolol

September 1975
British Medical Journal;9/27/1975, Vol. 3 Issue 5986, p735
Academic Journal
Examines the improvement in prognosis of myocardial infarction. Use of practolol in the administration of a long-term beta-adrenoreceptor blockade; Reduction in overall mortality and in sudden deaths; Role of sympathetic nervous activity in precipitating sudden death after infarction.


Related Articles

  • Beta--Blockers after Myocardial Infarction: Influence of First--Year Clinical Course on Long--Term Effectiveness. Viscoli, Catherine M.; Horwitz, Ralph I.; Singer, Burton H. // Annals of Internal Medicine;1/15/93, Vol. 118 Issue 2, p99 

    Presents a study that examined the influence of first year clinical course on the long-term effectiveness of the beta-blocker propranolol after myocardial infarction. Assessment of the mortality rates; Analysis of changes in the treatment of patients; Evaluation of the effectiveness of...

  • Post-MI therapy: Low-dose beta blockers may be as good as, maybe better than, high-dose.  // Geriatrics;Jun98, Vol. 53 Issue 6, p98 

    Presents a summary of the article `Beta-blocker dosages and mortality after myocardial infarction: Data from a large health maintenance organization,' by H.V. Barron, S. Viskin, R.J. Lundstrom and others, published in the March 9, 1998 issue of the `Archives of Internal Medicine' periodical.

  • Should every survivor of a heat attack be given a beta-blocker? Hampton, J.R.; Breckenridge, A.; Rose, Geoffrey // British Medical Journal (Clinical Research Edition);7/3/1982, Vol. 285 Issue 6334, p33 

    Part I, II and III. Focuses on the use of a beta-blocker in survivor of heart attack in Great Britain. Difficulty to use beta-blockers in the initial stages of a heart attack; Reduction of mortality in patients treated with beta-blockers; Administration of beta-blockers in patients due to...

  • Confidence in results of beta-blocker postinfarction trials. Baber, N.S.; Lewis, J.A. // British Medical Journal (Clinical Research Edition);6/12/1982, Vol. 284 Issue 6331, p1749 

    Examines the results of beta-blockers in myocardial infarctions. Reduction of mortality; Temporal distribution of trial admission; Improvements of technique for calculating confidence limits.

  • Half of MI patients don't get beta blockers; those who don't get enough.  // Modern Medicine;Sep95, Vol. 63 Issue 9, p38 

    Presents an abstract of the report `Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice,' by S. Viskin et. al. published on the May 1995 issue of `Journal of American College of Cardiology'.

  • A new multimodal approach to evaluate the risk of sudden death. Chevalier, Philippe // Kardio List;Mar/Apr2012, Vol. 7 Issue 3/4, p105 

    Myocardial infaction (Ml) leads to ventricular sympathetic denervation followed by sympathetic reinnervation. Although the extent and characteristics of such reservation remain uncertain, it is clear that infarction results in the heterogeneous distribution of sympathetic innervation and thus in...

  • Drugs for elderly are not always used wisely.  // HealthFacts;Feb97, Vol. 22 Issue 2, p3 

    Reports about the under-prescription of beta-blocker drugs for the elderly who survived a heart attack. Heavy promotion of calcium channel blockers by drug companies to doctors; Association of calcium channel blockers with doubled risk of death; Percentage of patients in the study who received...

  • Avoid switching calcium antagonists for beta-blockers post-MI.  // Geriatrics;Mar97, Vol. 52 Issue 3, p16 

    Reports that the substitution of calcium antagonists for more effective beta blockers in older post-acute myocardial infarction patients results to reduced mortality, based on a study by Stephen Soumerai and colleagues. Less probability of receiving beta blockers among older patients.

  • Post-MI beta blocker dosing: Lower may be better.  // Formulary;Jun98, Vol. 33 Issue 6, p596 

    Reveals that dosages of discharge beta blockers used in clinical studies of mycordial infarction (MI) may be higher than necessary, according to report researchers in the San Francisco, California, area. Reduced cardiovascular mortality associated with low-dose therapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics